Immune molecules could be targets for autism treatments, the battle for CRISPR’s patent may be nearing an end, and a plan to give postdoctoral researchers overtime pay is scuttled.

The 21st Century Cures Act, having passed the U.S. Senate, now goes to President Barack Obama, who has promised to sign it.

A sprawling health bill expected to pass the U.S. Senate and become law before the end of the year is a grab bag for industries that spent plenty of money lobbying to make sure it happened that way.

Scientists are nervous about the next four years, grant money is making preprints more common, and researchers should grab a beer with a science writer.

More than 1,455 lobbyists representing 400 companies, universities and other organizations have pushed for or against an earlier House version of the 21st Century Cures bill.

A new bill threatens to lower the scientific standards that have made the Food and Drug Administration’s approval the gold standard worldwide.

If passed, the $6.3 billion 21st Century Cures Act would make mental health a national priority.

Some say a focus on basic neuroscience is crushing clinical research, a gene database gets a big upgrade, and Autism Speaks revises its goals.

Spectrum’s team reported about 50 stories at the Society for Neuroscience annual meeting in San Diego. One big theme this year: how autism relates to bigger questions in neuroscience.

Researchers in a relationship may have trouble finding jobs in the same place, but some pairs see this as an opportunity.